These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1011 related items for PubMed ID: 18424568

  • 1. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
    Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Farahmand BY, Winchester CC, Roda E, Bazzoli F.
    Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
    [Abstract] [Full Text] [Related]

  • 2. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
    Koek GH, Sifrim D, Lerut T, Janssens J, Tack J.
    Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
    [Abstract] [Full Text] [Related]

  • 3. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R.
    Aliment Pharmacol Ther; 2006 Jan 15; 23(2):321-9. PubMed ID: 16393313
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M, Manno M, De Micheli E, Savarino V.
    Dig Liver Dis; 2006 Sep 15; 38(9):643-8. PubMed ID: 16627016
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
    Peng S, Cui Y, Xiao YL, Xiong LS, Hu PJ, Li CJ, Chen MH.
    Endoscopy; 2009 Dec 15; 41(12):1011-7. PubMed ID: 19967617
    [Abstract] [Full Text] [Related]

  • 6. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
    Veldhuyzen van Zanten SJ, Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Escobedo S, Sinclair P.
    Aliment Pharmacol Ther; 2006 Mar 01; 23(5):595-9. PubMed ID: 16480398
    [Abstract] [Full Text] [Related]

  • 7. Barrett's oesophagus: a clinical study of 52 patients.
    Cooper BT, Barbezat GO.
    Q J Med; 1987 Feb 01; 62(238):97-108. PubMed ID: 3498962
    [Abstract] [Full Text] [Related]

  • 8. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
    Ladanchuk TC, Johnston BT, Murray LJ, Anderson LA, FINBAR study group.
    Scand J Gastroenterol; 2010 Dec 01; 45(12):1397-403. PubMed ID: 20626305
    [Abstract] [Full Text] [Related]

  • 9. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C.
    Gut; 2004 Aug 01; 53(8):1070-4. PubMed ID: 15247170
    [Abstract] [Full Text] [Related]

  • 10. Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study.
    Zagari RM, Law GR, Fuccio L, Pozzato P, Forman D, Bazzoli F.
    Am J Gastroenterol; 2010 Mar 01; 105(3):565-71. PubMed ID: 20010920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M.
    Aliment Pharmacol Ther; 2004 Dec 01; 20 Suppl 8():50-4. PubMed ID: 15575874
    [Abstract] [Full Text] [Related]

  • 14. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
    Ortiz Escandell A, Martínez de Haro LF, Parrilla Paricio P, Molina Martínez J, Aguayo Albasini JL, Martínez Gómez D.
    Rev Esp Enferm Dig; 1990 Mar 01; 77(3):171-5. PubMed ID: 2378753
    [Abstract] [Full Text] [Related]

  • 15. Gastroesophageal reflux and related pathology in adults who were born with esophageal atresia: a long-term follow-up study.
    Taylor AC, Breen KJ, Auldist A, Catto-Smith A, Clarnette T, Crameri J, Taylor R, Nagarajah S, Brady J, Stokes K.
    Clin Gastroenterol Hepatol; 2007 Jun 01; 5(6):702-6. PubMed ID: 17544997
    [Abstract] [Full Text] [Related]

  • 16. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
    McDougall NI, Johnston BT, Collins JS, McFarland RJ, Love AH.
    Eur J Gastroenterol Hepatol; 1997 Dec 01; 9(12):1161-7. PubMed ID: 9471021
    [Abstract] [Full Text] [Related]

  • 17. Barrett's esophagus: prevalence in symptomatic relatives.
    Romero Y, Cameron AJ, Schaid DJ, McDonnell SK, Burgart LJ, Hardtke CL, Murray JA, Locke GR.
    Am J Gastroenterol; 2002 May 01; 97(5):1127-32. PubMed ID: 12017151
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB, Boparai V, Ullah N, Triadafilopoulos G.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):637-43. PubMed ID: 15352912
    [Abstract] [Full Text] [Related]

  • 20. Leptin and the risk of Barrett's oesophagus.
    Kendall BJ, Macdonald GA, Hayward NK, Prins JB, Brown I, Walker N, Pandeya N, Green AC, Webb PM, Whiteman DC, Study of Digestive Health.
    Gut; 2008 Apr 15; 57(4):448-54. PubMed ID: 18178609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.